Erubin

10 mg

50 mg

💊 Available Strengths & Packaging

• Erubin 10 mg Injection – typically provided as 10 mg in a single-use vial 

• Erubin 50 mg Injection – available as 50 mg per vial .

---

✔️ Indications (Uses)

Both strengths are used under medical supervision (IV infusion) to treat a variety of cancers. Common indications include:

• Breast, stomach (gastric), ovarian, lung (including small-cell), and soft-tissue sarcomas

• Bladder cancers (particularly to help prevent recurrence post-surgery)

• Certain blood/lymph cancers (leukemia, lymphoma)

• Also used for head/neck, liver, pancreatic, and colorectal cancers 

---

🚀 Mechanism of Action

Epirubicin disrupts cancer cell replication by:

1. Intercalating into DNA, disrupting helix structure

2. Inhibiting topoisomerase II, blocking DNA replication

3. Generating free radicals, leading to further DNA damage and cell death 

---

🏥 Administration & Dosage

• Route: Intravenous infusion (IV), typically via drip by trained professionals only .

• Dosage: Determined individually by oncologists based on cancer type, stage, body surface area (BSA), and health status. May be combined with other chemo agents 

• Scheduling varies—usually given in cycles (weeks apart).

---

⚠️ Safety & Precautions

• Pregnancy & breastfeeding: CONTRAINDICATED. Causes fertility risk; use contraception during and for ~6 months after therapy .

• Heart conditions: High risk of cardiotoxicity—avoid in heart failure or prior anthracycline therapy 

• Liver disease: Dose adjustments may be required; contraindicated in severe hepatic impairment .

• Kidney disease: Generally considered safe, though monitor closely and adjust if severe dysfunction 

• Vesicant properties: Can cause tissue damage/blistering if it extravasates—strict IV protocols enforced 

• Interactions: Antihypertensives, digoxin, paclitaxel, cimetidine, CYP modulators and warfarin may affect effects and toxicity 

---

🤒 Common Side Effects

• Myelosuppression: Low WBC, platelets—increased infection risk .

• GI: Nausea, vomiting, diarrhea, mouth sores 

• Alopecia (hair loss) .

• Red/orange urine discoloration (harmless but common) .

• Fatigue, appetite loss, fever, rash 

• Cardiac effects: Irregular heartbeat, potential cardiomyopathy .

• Injection-site reactions if infiltration occurs .

---

🧊 Storage

• Keep in a refrigerator (2–8 °C); do not freeze.

• Shield from light and heat; discard per hospital protocol